This is a continuation application by the Ontario Familial Colorectal Cancer Registry (OFCCR), an active member of the Cooperative Family Registries for Colorectal Cancer Studies (CFR), to complete, maintain, update and expand our infrastructure of data and biospecimens, for current and future collaborative studies in the broad area of colorectal cancer research. Over the past four years, the OFCCR has collected family history data, personal risk factor and food frequency information, blood and tumor samples from over 1,300 incident colorectal cancer cases identified by the Ontario Cancer Registry, using common protocols developed by the 6 CFR centers. We are also collecting similar data from over 4,000 relatives of the aforementioned probands and about 900 age and sex-matched (to the probands) population controls. This large infrastructure will now be augmented for further collaborative genetic studies by: 1) accruing incident colorectal cancer cases less than age 50 in Ontario (and family members) from 2003 to 2007; 2) registering and expanding prevalent high risk colorectal cancer kindreds from the Familial GI Cancer Registry in Toronto, and 3) enhancing a newly formed collaboration with colleagues in Newfoundland who are developing a similar family-based colorectal cancer registry. In addition, the OFCCR, in cooperation with the CFRs, will develop and implement both active and passive follow-up protocols for existing and newly recruited subjects as well as family members. These activities will ensure the maintenance of a high quality, and up-to-date family registry which will be used both locally, and in collaboration with other scientists, in studies of gene-gene interactions, gene-environment interactions, genetic epidemiology, pharmacogenomics, gene discovery, psychosocial and behavioral research. The OFCCR will also be a rich resource of high-risk subjects for future recruitment into colorectal cancer prevention trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01CA074783-05
Application #
6550988
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (M1))
Program Officer
Seminara, Daniela
Project Start
1997-09-30
Project End
2007-06-30
Budget Start
2002-09-30
Budget End
2003-06-30
Support Year
5
Fiscal Year
2002
Total Cost
$1,803,269
Indirect Cost
Name
Cancer Care Ontario
Department
Type
DUNS #
243657665
City
Toronto
State
ON
Country
Canada
Zip Code
M5 2-L7
Pande, Mala; Joon, Aron; Brewster, Abenaa M et al. (2018) Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13:e0196245
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Jenkins, Mark A; Win, Aung Ko; Templeton, Allyson S et al. (2018) Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol 47:387-388i
Dashti, S Ghazaleh; Win, Aung Ko; Hardikar, Sheetal S et al. (2018) Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer 143:2250-2260
Jeon, Jihyoun; Du, Mengmeng; Schoen, Robert E et al. (2018) Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology 154:2152-2164.e19
Wang, Xiaoliang; Chan, Andrew T; Slattery, Martha L et al. (2018) Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk. Cancer Res 78:4790-4799
Hart, Tae L; Charles, Susan T; Gunaratne, Mekhala et al. (2018) Symptom Severity and Quality of Life Among Long-term Colorectal Cancer Survivors Compared With Matched Control Subjects: A Population-Based Study. Dis Colon Rectum 61:355-363
Hua, Xinwei; Phipps, Amanda I; Burnett-Hartman, Andrea N et al. (2017) Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival. J Clin Oncol 35:2806-2813
Dienstmann, R; Mason, M J; Sinicrope, F A et al. (2017) Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol 28:1023-1031
Raskin, Leon; Guo, Yan; Du, Liping et al. (2017) Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort. Oncotarget 8:93450-93463

Showing the most recent 10 out of 210 publications